Literature DB >> 18950648

Cyclobutane pyrimidine dimers do not fully explain the mutagenicity induced by UVA in Chinese hamster cells.

Anna Biverstål1, Fredrik Johansson, Dag Jenssen, Klaus Erixon.   

Abstract

UVA generates low levels of cyclobutane pyrimidine dimers (CPDs). Here we asked the question whether CPDs could fully explain the level of mutations induced by UVA. Relative mutagenicities of UVA and UVC were calculated at equal levels of CPDs in cell lines, deficient in different aspects of repair. Survival and gene mutations in the hprt locus were analyzed in a set of Chinese hamster ovary (CHO) cell lines, i.e., wild-type, Cockayne syndrome B protein-deficient (CSB), XRCC3-deficient and XRCC1-deficient adjusted to the same level of CPDs which was analyzed as strand breaks as a result of DNA cleavage by T4 endonuclease V at CPD sites. Induced mutagenicity of UVA was approximately 2 times higher than the mutagenicity of UVC in both wild-type and XRCC1-deficient cells when calculated at equal level of CPDs. Since this discrepancy could be explained by the fact that the TT-dimers, induced by UVA, might be more mutagenic than C-containing CPDs induced by UVC, we applied acetophenone, a photosensitizer previously shown to generate enhanced levels of TT-CPDs upon UVB exposure. The results suggested that the TT-CPDs were actually less mutagenic than the C-containing CPDs. We also found that the mutagenic effect of UVA was not significantly enhanced in a cell line deficient in the repair of CPDs. Altogether this suggests that neither base excision- nor nucleotide excision-repair was involved. We further challenge the possibility that the lesion responsible for the mutations induced by UVA was of a more complex nature and which possibly is repaired by homologous recombination (HR). The results indicated that UVA was more recombinogenic than UVC at equal levels of CPDs. We therefore suggest that UVA induces a complex type of lesion, which might be an obstruction during replication fork progression that requires HR repair to be further processed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18950648     DOI: 10.1016/j.mrfmmm.2008.09.011

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  7 in total

1.  Response to Emanuele.

Authors:  Quentin Gueranger; Feng Li; Matthew Peacock; Annabel Larnicol-Fery; Reto Brem; Peter Macpherson; Jean-Marc Egly; Peter Karran
Journal:  J Invest Dermatol       Date:  2014-02-03       Impact factor: 8.551

Review 2.  Roles of UVA radiation and DNA damage responses in melanoma pathogenesis.

Authors:  Aiman Q Khan; Jeffrey B Travers; Michael G Kemp
Journal:  Environ Mol Mutagen       Date:  2018-02-21       Impact factor: 3.216

3.  Chinese hamster apurinic/apyrimidinic endonuclease (chAPE1) expressed in sf9 cells reveals that its endonuclease activity is regulated by phosphorylation.

Authors:  Mandula Borjigin; Bobbie Martinez; Sarla Purohit; Gaudalupe de la Rosa; Pablo Arenaz; Boguslaw Stec
Journal:  FEBS J       Date:  2010-10-19       Impact factor: 5.542

4.  Implication of SUMO E3 ligases in nucleotide excision repair.

Authors:  Maasa Tsuge; Hidenori Kaneoka; Yusuke Masuda; Hiroki Ito; Katsuhide Miyake; Shinji Iijima
Journal:  Cytotechnology       Date:  2014-07-10       Impact factor: 2.058

5.  Oxidative stress in mammalian cells impinges on the cysteines redox state of human XRCC3 protein and on its cellular localization.

Authors:  Pierre-Marie Girard; Dany Graindorge; Violetta Smirnova; Pascal Rigolet; Stefania Francesconi; Susan Scanlon; Evelyne Sage
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

Review 6.  Protein oxidation, UVA and human DNA repair.

Authors:  Peter Karran; Reto Brem
Journal:  DNA Repair (Amst)       Date:  2016-05-20

7.  UVA-induced DNA double-strand breaks result from the repair of clustered oxidative DNA damages.

Authors:  R Greinert; B Volkmer; S Henning; E W Breitbart; K O Greulich; M C Cardoso; Alexander Rapp
Journal:  Nucleic Acids Res       Date:  2012-08-30       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.